ARTICLE | Clinical News
Medarex preclinical data
May 4, 2009 7:00 AM UTC
MDX-1204, a human antibody against mesothelin conjugated to a DNA alkylating agent, had significant anti-tumor activity and was well tolerated in monkey and mouse models of lung cancer. Data were pre...